Cramer's lightning round: This downtrodden stock's no more than a value play

Source: CNBC. Jim Cramer flew through his take on callers' favorite stocks, including a pharmaceutical play undergoing a turnaround.·CNBC

It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Xerox (NYSE: XRX): "Pain! No, that's for Mr. T. Look, I just don't think Xerox has any catalysts. I just can't recommend the stock. I thought that there was more to it. It's a value play, but not more than that."

Alere (NYSE: ALR): "Alere's going away, Abbott's (NYSE: ABT) buying them. That deal will close. My charitable trust owns Abbott. I think Abbott is the next one to roar."

Huntsman Corporation (NYSE: HUN): "That's another one that's being taken over. Forget it."

Xilinx (NASDAQ: XLNX): "I think Xilinx will be taken over. I think Xilinx is an inexpensive stock. [CEO] Moshe Gavrielov has really turned it around. I'm a buy, buy, buyer of Xilinx."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com



More From CNBC

Advertisement